We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
PMV Pharmaceuticals
PMVP
$63.5M
| $859K | ﹤0.01% |
98,697
-17,714
| -15% | -$189K |
|
|
ZYXI
2702
DELISTED
Zynex
ZYXI
| $856K | ﹤0.01% |
61,510
-4,686
| -7% | -$56.6K |
|
2703
Blend Labs
BLND
$386M
| $855K | ﹤0.01% |
593,845
-57,250
| -9% | -$103K |
|
|
SPNE
2704
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $852K | ﹤0.01% |
101,987
-18,608
| -15% | -$125K |
|
2705
Bridgford Foods
BRID
$56.5M
| $849K | ﹤0.01% |
70,834
| – | – |
|
2706
Radware
RDWR
$1.19B
| $849K | ﹤0.01% |
42,978
-7,549
| -15% | -$158K |
|
2707
UWM Holdings
UWMC
$434M
| $849K | ﹤0.01% |
256,290
+10,254
| +4% | +$38.4K |
|
2708
Daily Journal
DJCO
$778M
| $841K | ﹤0.01% |
3,358
-582
| -15% | -$157K |
|
|
ONTF
2709
DELISTED
ON24
ONTF
| $838K | ﹤0.01% |
97,100
-19,934
| -17% | -$160K |
|
2710
Pliant Therapeutics
PLRX
$65M
| $835K | ﹤0.01% |
+43,222
| New | +$904K |
|
2711
iShares Russell 2000 Value ETF
IWN
$14.6B
| $833K | ﹤0.01% |
+6,005
| New | +$848K |
|
|
AMPS
2712
DELISTED
Altus Power
AMPS
| $832K | ﹤0.01% |
127,555
-14,175
| -10% | -$116K |
|
|
KLRS
2713
Kalaris Therapeutics
KLRS
$96.8M
| $831K | ﹤0.01% |
7,042
-638
| -8% | -$108K |
|
2714
Precigen
PGEN
$2.59B
| $830K | ﹤0.01% |
545,918
-64,575
| -11% | -$111K |
|
2715
BCB Bancorp
BCBP
$161M
| $828K | ﹤0.01% |
46,049
-9,790
| -18% | -$183K |
|
2716
Civista Bancshares
CIVB
$589M
| $817K | ﹤0.01% |
37,098
-7,427
| -17% | -$167K |
|
2717
DHI Group
DHX
$173M
| $815K | ﹤0.01% |
154,166
-101,584
| -40% | -$564K |
|
2718
RxSight
RXST
$260M
| $810K | ﹤0.01% |
63,878
-3,587
| -5% | -$43.6K |
|
2719
OmniAb
OABI
$447M
| $808K | ﹤0.01% |
+224,414
| New | +$1.18M |
|
|
MCBC
2720
DELISTED
Macatawa Bank Corp
MCBC
| $808K | ﹤0.01% |
73,206
-18,077
| -20% | -$192K |
|
2721
SmartRent
SMRT
$272M
| $804K | ﹤0.01% |
330,884
-17,245
| -5% | -$42.6K |
|
2722
Janux Therapeutics
JANX
$967M
| $799K | ﹤0.01% |
60,717
-12,160
| -17% | -$178K |
|
2723
Ituran Location and Control
ITRN
$1.05B
| $797K | ﹤0.01% |
37,715
-1,500
| -4% | -$34.2K |
|
2724
Astronics
ATRO
$3.84B
| $796K | ﹤0.01% |
92,719
-19,793
| -18% | -$146K |
|
2725
Rush Street Interactive
RSI
$2.88B
| $794K | ﹤0.01% |
221,127
-4,983
| -2% | -$18.5K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.